Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.30%3.36B | 0.43%3B | 2.45%775.99M | 0.38%797.88M | 6.49%2.98B | 703.96M | 2.35%726.17M | 15.99%757.43M | 13.27%794.84M | 38.84%2.8B |
| Cost of revenue | 10.07%2.48B | 2.20%2.25B | 7.07%584.6M | 7.33%596.74M | 5.02%2.2B | 535.73M | 5.67%564.17M | 11.36%545.98M | 5.98%555.98M | 48.18%2.1B |
| Gross profit | 19.03%886.62M | -4.57%744.84M | -9.48%191.39M | -15.79%201.14M | 10.86%780.55M | 168.23M | -7.74%162.01M | 29.97%211.45M | 34.87%238.86M | 16.91%704.09M |
| Operating expense | 0.04%658.91M | 2.65%658.66M | 1.74%162.88M | 1.46%165.66M | 5.25%641.67M | 157.9M | 4.60%160.4M | 6.59%160.1M | 11.41%163.28M | 10.78%609.65M |
| Staff costs | -2.85%448.7M | 2.03%461.87M | ---- | ---- | 12.41%452.7M | ---- | ---- | ---- | ---- | 9.52%402.72M |
| Selling and administrative expenses | 5.19%23.82M | -35.19%22.64M | ---- | ---- | -40.61%34.93M | ---- | ---- | ---- | ---- | 21.92%58.82M |
| -General and administrative expense | 5.19%23.82M | -35.19%22.64M | ---- | ---- | -40.61%34.93M | ---- | ---- | ---- | ---- | 21.92%58.82M |
| Depreciation and amortization | -14.26%2.09M | -11.91%2.43M | ---- | ---- | -3.05%2.76M | ---- | ---- | ---- | ---- | 16.04%2.85M |
| -Depreciation | -14.26%2.09M | -11.91%2.43M | ---- | ---- | -3.05%2.76M | ---- | ---- | ---- | ---- | 16.04%2.85M |
| Rent and land expenses | 0.00%34.8M | 0.00%34.8M | ---- | ---- | 0.00%34.8M | ---- | ---- | ---- | ---- | 0.00%34.8M |
| Other operating expenses | 9.20%149.5M | 17.55%136.91M | ---- | ---- | 5.44%116.47M | ---- | ---- | ---- | ---- | 13.73%110.46M |
| Operating profit | 164.22%227.71M | -37.94%86.18M | -44.48%28.51M | -53.07%35.47M | 47.05%138.87M | 10.34M | -92.79%1.61M | 311.18%51.35M | 147.41%75.58M | 81.88%94.44M |
| Net non-operating interest income (expenses) | 214.80%1.17M | -6,900.00%-1.02M | -4,085.71%-279K | -283K | 7.14%15K | 8K | 0 | 7K | 0 | 16.67%14K |
| Non-operating interest income | 1,605.88%2.32M | 806.67%136K | ---- | ---- | 7.14%15K | --8K | --0 | ---- | ---- | 16.67%14K |
| Non-operating interest expense | -0.61%1.15M | --1.16M | --287K | --283K | --0 | ---- | ---- | --0 | --0 | ---- |
| Net investment income | -285.35%-605K | 60.88%-160K | -121.19%-284K | 93.96%-157K | 54K | -245.02%-1.14M | 50.60%-409K | 508.54%1.34M | -138.84%-2.6M | |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -70.28%576K | 470.00%1.94M | 547.34%1.34M | 2,700.00%560K | -46.03%340K | 128K | -106.67%-15K | -46.37%207K | -37.50%20K | -47.41%630K |
| Income before tax | 165.28%229.45M | -37.80%86.49M | -42.51%29.41M | -53.91%35.46M | 50.38%139.07M | 10.52M | -97.97%450K | 324.49%51.16M | 154.34%76.94M | 106.89%92.48M |
| Income tax | 173.51%72.74M | -30.07%26.59M | -41.77%9.87M | -52.58%11.46M | 43.44%38.03M | -3.78M | -90.97%696K | 246.22%16.94M | 124.03%24.16M | 30.66%26.51M |
| Net income | 161.63%156.71M | -40.72%59.9M | -42.87%19.54M | -54.52%24M | 53.17%101.04M | 14.3M | -101.70%-246K | 377.94%34.21M | 171.14%52.77M | 170.28%65.97M |
| Net income continuous operations | 161.63%156.71M | -40.72%59.9M | -42.88%19.54M | -54.51%24.01M | 53.17%101.04M | --14.3M | -101.70%-246K | 378.01%34.21M | 171.13%52.78M | 170.27%65.97M |
| Noncontrolling interests | 19.99%3.23M | 1,659.48%2.69M | 98.27%458K | 128.41%50K | 103.31%153K | 27K | 110.09%71K | 117.20%231K | 87.94%-176K | 13.43%-4.63M |
| Net income attributable to the company | 168.30%153.48M | -43.30%57.21M | -43.83%19.09M | -54.76%23.95M | 42.91%100.88M | 14.27M | -102.10%-318K | 299.72%33.98M | 153.06%52.95M | 137.27%70.59M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 168.30%153.48M | -43.30%57.21M | -43.83%19.09M | -54.76%23.95M | 42.91%100.88M | 14.27M | -102.10%-318K | 299.72%33.98M | 153.06%52.95M | 137.27%70.59M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 173.68%47.32 | -43.81%17.29 | -44.19%5.76 | -55.35%7.26 | 40.44%30.77 | 4.33 | -102.99%-0.14 | 300.00%10.32 | 145.62%16.26 | 125.41%21.91 |
| Diluted earnings per share | 175.16%46.75 | -43.27%16.99 | -43.75%5.67 | -54.83%7.11 | 42.35%29.95 | 4.23 | -103.10%-0.14 | 296.85%10.08 | 152.24%15.74 | 135.61%21.04 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |